MEAGHAN GAVAN: Open Payments
NPI 1881029007 · EATONTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,179 in 68 payments from 13 companies in 2025. Trend: 2023 $969 · 2024 $1,349 · 2025 $1,179
Food & beverage: $1,066Education: $113
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $300 |
| Janssen Biotech, Inc. | 7 | $205 |
| Galderma Laboratories, L.P. | 9 | $154 |
| Novartis Pharmaceuticals Corporation | 6 | $123 |
| Regeneron Healthcare Solutions, Inc. | 5 | $86 |
| Arcutis Biotherapeutics, Inc. | 5 | $85 |
| Lilly USA, LLC | 3 | $54 |
| E.R. Squibb & Sons, L.L.C. | 3 | $48 |
| LEO Pharma Inc. | 2 | $37 |
| Amgen Inc. | 2 | $35 |
Products named: TREMFYA, SKYRIZI, NEMLUVIO, RINVOQ, COSENTYX, DUPIXENT, Zoryve, TALTZ.
Industry payments across NJ — which companies pay providers there.
